Company Long-Term Loans and Borrowings: omeros.com (OMER)

Graphic logo of omeros.com (OMER)

The following Omeros Corporation (OMER) quotes illustrate the debt dynamics of the company, which currently stands at 0.00. The business relies on external contractors for drug manufacturing, prioritizing scientific research. Intellectual property protection and stringent certification standards block generic competitors from entering the market. The financial future depends on FDA verdicts and support from investment funds within the framework of clinical trials.

Omeros (OMER) Company Long-Term Debt: for the period 07/04/2022 - 11/01/2026

Omeros (OMER) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price Omeros Corp|OMER - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Omeros|OMER - Total Company Value
- book capitalization information:
Net Asset Value per Share Omeros|OMER - Company Book Value|Market-to-Book Ratio omeros.com|OMER - Aggregate Company Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio Omeros Corporation|OMER - Long-Term Debt to Capital|Current Liabilities to Capital Omeros Corp|OMER - Company Debts|Debt to Net Assets Ratio Omeros|OMER - Company Long-Term Debt|Short-Term Debt Omeros|Interim Coverage Ratio omeros.com
- earnings and market multiples details:
OMER - Net Income
Analysis of all company metrics:Omeros Corporation
Mass-produced product of omeros.com

This metric aggregates all financial obligations with maturities exceeding twelve months, reflecting the business's long-term credit burden. Analyzing the volume of long-term debt allows for an assessment of liquidity gap risks and the future cost of debt service. An increase in this metric signals capital scaling, which is critical under high interest burdens. For Omeros Corporation (OMER), such funds are typically directed toward costly R&D developments in the field of complement inhibitors.

Competitors of Omeros Corporation (OMER)

Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|Company Long-Term Debt Xenon Pharmaceuticals|Long-Term Debt vikingtherapeutics.com VKTX|Company Long-Term Debt Supernus (SUPN)|Company Long-Term Liabilities Catalyst Pharma CPRX|Company Long-Term Debts DNLI (Denali Therapeutics Inc)|Harmony Corp (HRMY) - Long-Term Debt|BHVN - Company Long-Term Debt|Company Long-Term Loans and Borrowings AMLX (amylyx.com)|Trevi Therapeutics, Inc. (TRVI) - Company Long-Term Debt|Long-Term Debt Praxis Precision Medicines Inc (PRAX)|Company Long-Term Debt Anavex Corp|CeriBell EEG (CBLL) - Long-Term Debt Volume|Company Long-Term Liabilities PRTA (Prothena)|ALEC (alector.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts ANNX (Annexon)|NGNE - Company Long-Term Liabilities|ACIU - Company Long-Term Debt|Long-Term Debt Voyager Corp|Neumora Therapeutics (NMRA) - Company Long-Term Debt|scilexholding.com - Company Long-Term Loans and Borrowings|Company Long-Term Debt Tevogen Bio|Alpha Cognition Corp - Long-Term Liabilities|Company Long-Term Debt Cognition Therapeutics (CGTX)|IKT - Long-Term Debt|Company Long-Term Debt Cassava Sciences, Inc. SAVA|Company Long-Term Loans and Borrowings ASRT|Coya - Company Long-Term Debts|VTGN - Company Long-Term Debts|OVID (ovidrx.com) - Company Long-Term Liabilities|ABOS: Amount of Long-Term Liabilities|CRVO (CervoMed Inc.) - Company Long-Term Debts|Alterity Therapeutics Ltd (ATHE) - Long-Term Debt Volume|Company Long-Term Debt Clene Inc. (CLNN)|PEPG - Long-Term Debt|Company Long-Term Debt Jupiter Neurosciences Inc JUNS|RLMD: Company Long-Term Indebtedness|ANVS - Company Long-Term Debt|Long-Term Debt Grace Therapeutics, Inc.|Firefly Neuroscience (AIFF) - Company Long-Term Debt|Company Long-Term Liabilities Klotho Neurosciences|NRSN (NeuroSense Therapeutics Ltd) - Company Long-Term Debts|Long-Term Debt Reviva Pharmaceuticals, Inc. RVPH|Company Long-Term Debt MetaVia Inc (MTVA)|NRXS (neuraxis.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Helius Medical Technologies HSDT|PASG: Company Long-Term Indebtedness|Neuphoria - Company Long-Term Debts|Long-Term Debt Minerva|ATHA (Athira Pharma, Inc.) - Company Long-Term Liabilities|addextherapeutics.com (ADXN) - Company Long-Term Debts|Company Long-Term Debt Alzamend Neuro Inc.|CYCN: Company Long-Term Loans and Borrowings|Company Long-Term Debt Protagenic Therapeutics (PTIX)|KTTA - Long-Term Debt|Company Long-Term Debt Cortigent CRGT|avenuetx.com (ATXI) - Long-Term Debt|BCLI - Company Long-Term Debt|Cara Therapeutics Inc. (CARA) - Company Long-Term Liabilities|CHRO: Company Long-Term Debts|Long-Term Debt Eliem Therapeutics Inc. (ELYM)|Company Long-Term Debt Intra-Cellular Therapies Inc.|LBPH: Company Long-Term Loans and Borrowings|Company Long-Term Debt Marinus Pharmaceuticals, Inc. (MRNS)|NKGN - Long-Term Debt|Company Long-Term Debt NeuroBo NRBO|Long-Term Debt Volume Sage Therapeutics Inc (SAGE)|SNPX: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings TRVN (trevena.com)|VIGL: Company Long-Term Debts|Company Long-Term Liabilities Anew Medical Inc.|Company Long-Term Debt Cerevel